Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Northwick Park Institute For Medical Research

The Grifn Institute - Improving and Extending Patients' Lives

Northwick Park Institute For Medical Research is a UK company with status active founded in 1997 based in London.

CRN
03445616
Founded
1997
Age
28

Overview

Legal name
NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH
Region
London
Registered address
NORTHWICK PARK AND ST MARK'S HOSPITALS
WATFORD ROAD
HARROW
MIDDLESEX
ENGLAND
HA1 3UJ
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Northwick Park Institute For Medical Research
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

8 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

20 Oct
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

06 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

25 Nov
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0NDc2Mjk5NmFkaXF6a2N4

Published 25 Nov 2024 11:55

02 Sep
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzNDE3NDkxMGFkaXF6a2N4

Published 02 Sep 2024 16:38

02 Sep
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzNDE3NDcwM2FkaXF6a2N4

Published 02 Sep 2024 16:36

07 Oct
1997

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2010
Funded years
2010, 2016
Age at first award
12 years

Projects

2016 GRD Proof of Concept Lead participant

NuAIR stent: A respiratory stent inspired by nature, achieved through cutting edge architecture and engineering

1 Feb 2016 to 31 Jan 2017

Awarded
£76,075
Total cost £126,792

Airway obstructions cause breathlessness and difficulty swallowing. They occur in up to 30% of lung cancer patients, where prognosis is often poor and palliative treatment the only option. Additionally, there were over 2,000 patients suffering from tracheomalacia (collapsed airway) and stenosis (abnormal narrowing of the airway) in the UK last year. The c...

2010 Fast Track

Evaluation, Manufacturing Scale up and Regulatory Validation of FibroFix: a Mechanically Advanced, Tissue Regenerative, Meniscal Cartilage Repair Device

1 Jul 2010 to 31 Mar 2011

Awarded
£125,119
Total cost £125,119

Awaiting Public Summary

2010 Fast Track

Evaluation of a tissue regenerative load bearing two phase silk-hydroxyapatite composite scaffold in large legion osteochondral knee cartilage regeneration

1 Jul 2010 to 31 Mar 2011

Awarded
£96,257
Total cost £96,257

Awaiting Public Summary

Product types

Fast Track GRD Proof of Concept